| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 2.33B | 2.32B | 2.38B | 2.42B | 1.79B |
| Gross Profit | 1.10B | 1.10B | 1.14B | 1.18B | 804.47M |
| EBITDA | 66.72M | 35.44M | 136.66M | 190.36M | -59.66M |
| Net Income | -18.89M | -16.83M | 71.92M | 114.85M | -56.03M |
Balance Sheet | |||||
| Total Assets | 1.34B | 1.33B | 1.46B | 1.56B | 1.59B |
| Cash, Cash Equivalents and Short-Term Investments | 34.01M | 35.16M | 47.99M | 320.52M | 215.09M |
| Total Debt | 485.09M | 522.94M | 580.43M | 632.64M | 734.04M |
| Total Liabilities | 788.57M | 758.69M | 849.46M | 959.63M | 1.02B |
| Stockholders Equity | 546.97M | 571.20M | 606.97M | 602.47M | 566.76M |
Cash Flow | |||||
| Free Cash Flow | 46.75M | 34.49M | -224.82M | 185.97M | 133.61M |
| Operating Cash Flow | 87.89M | 94.80M | -164.88M | 239.87M | 157.74M |
| Investing Cash Flow | -41.13M | -60.00M | -59.93M | -33.90M | -24.02M |
| Financing Cash Flow | -47.00M | -47.58M | -45.53M | -101.17M | -3.16M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | $521.77M | 9.06 | 8.78% | 3.12% | -6.22% | -22.81% | |
65 Neutral | $235.95M | 7.13 | 28.98% | 2.25% | -2.67% | -22.93% | |
63 Neutral | $312.23M | -157.06 | -0.13% | ― | 2.76% | 96.01% | |
62 Neutral | $417.13M | 50.89 | 2.79% | ― | 2.81% | ― | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
45 Neutral | $114.08M | -51.80 | ― | ― | -7.33% | -114.80% | |
38 Underperform | $89.34M | ― | ― | ― | -10.09% | 81.44% |
On January 29, 2026, Genesco announced that Chief Financial Officer Cassandra “Sandra” Harris had tendered her resignation effective March 6, 2026, to pursue opportunities outside the retail industry, with the company emphasizing that her departure was not related to any disagreement over operations, policies, or financial reporting. Harris agreed to stay on as a consultant and principal accounting officer from March 7, 2026, through the anticipated March 25, 2026 filing of Genesco’s fiscal 2026 Form 10-K, assist with an orderly transition, and participate in the company’s fourth-quarter and fiscal 2026 earnings call, for which she will be paid $12,000 in transition services fees. Genesco has launched a search for a permanent CFO, and effective March 6, 2026, President and CEO Mimi E. Vaughn—who previously served as CFO from 2015 to 2019—will assume the role of interim CFO without additional compensation, leading an experienced finance team to ensure continuity as the company seeks a strategic finance leader to support its long-term growth strategy and shareholder value ambitions.
The most recent analyst rating on (GCO) stock is a Hold with a $42.00 price target. To see the full list of analyst forecasts on Genesco stock, see the GCO Stock Forecast page.
On January 16, 2026, Genesco Inc. entered into a fourth amendment to its Fourth Amended and Restated Credit Agreement, extending the facility’s maturity to January 16, 2031 while maintaining the existing borrowing base calculations and collateral structure for both its U.S. and Canadian revolving credit lines. The amendment relaxes ongoing financial covenant compliance by only requiring a minimum fixed charge coverage ratio of 1.0:1.0 if excess availability falls below the greater of $22.5 million or 10% of the loan cap, updates the benchmark rate for Canadian borrowings to Term CORRA, removes the credit spread adjustment to lower Term SOFR-based interest on domestic borrowings, and revises the pricing grid so applicable margins now range from 1.25% to 1.75% on Term SOFR, Term CORRA and alternative currency loans and from 0.25% to 0.75% on domestic and Canadian prime-based loans, collectively improving the company’s funding flexibility and potentially lowering its financing costs.
The most recent analyst rating on (GCO) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Genesco stock, see the GCO Stock Forecast page.
On January 12, 2026, Genesco reported that for the fourth fiscal quarter-to-date period ended December 27, 2025, total comparable sales rose 9% year over year, driven by a 10% increase in same-store sales and a 9% gain in e-commerce, with Journeys Group posting a 12% comparable sales jump, Schuh up 6%, and Johnston & Murphy up 1%. Management highlighted strong holiday performance at Journeys with double-digit growth on top of last year’s double-digit gains, while noting that Schuh’s better-than-expected top line relied on heavier discounting amid a highly promotional U.K. footwear market and inventory cleanup efforts; reflecting these dynamics, the company raised its fiscal 2026 adjusted earnings outlook to at least $1.30 per share and said it would provide a fuller business and outlook update with its fourth-quarter and full-year results, as well as present its story to investors at the 2026 ICR Conference on January 12, 2026.
The most recent analyst rating on (GCO) stock is a Buy with a $39.00 price target. To see the full list of analyst forecasts on Genesco stock, see the GCO Stock Forecast page.